CAROLINE CONWAY: Open Payments
NPI 1346259694 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$479 in 16 payments from 7 companies in 2025. Trend: 2023 $231 · 2024 $307 · 2025 $479
Food & beverage: $479
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $201 |
| GlaxoSmithKline, LLC. | 5 | $100 |
| ABBVIE INC. | 2 | $56 |
| Daiichi Sankyo Inc. | 2 | $55 |
| Genmab U.S., Inc. | 1 | $29 |
| Caris MPI, Inc. | 1 | $28 |
| Organon LLC | 1 | $10 |
Products named: KEYTRUDA, JEMPERLI, ELAHERE, LYNPARZA, MI CANCER SEEK, DATROWAY, Enhertu, JADA SYSTEM.
Industry payments across LA — which companies pay providers there.
